Clinical trials are research studies that test new treatments to see if they're better than the current treatment options. They can also determine if the new treatments have any side effects. People who take part will help themselves and the lives of others with endometriosis. They will also have to access the latest treatment options.
By taking part, you contribute to advances in research, better treatments, and better patient outcomes.
Information about participating in endometriosis research at the centre
Endometriosis research projects at the Julia Argyrou Endometriosis Centre
Listing updated: 2 October 2024
Epworth in Victoria, Australia has a variety of research projects available for patients who meet predefined eligibility criteria. The majority of the research at JAECE requires people to be a patient at Epworth. Please contact us to find out whether you are eligible to participate in research.
If you have diagnosed or suspected endometriosis:
- Assessing change in anti-Mullerian hormone (ovarian reserve) associated with surgical excision vs conservative management of endometrioma
- Endometriosis Longitudinal Fertility Study (ELFS)
- NECST Registry
- LongSTEPPP Study
- Endo Barostat study - endometriosis and IBS
If you are planned/scheduled for surgery:
- MRI-ENDO
- JAECE Biobank
- Aetiology of Endometriosis
- Palmitoylethanolamide and polydatin
- EnD-IT: Better diagnosis of initial and recurrent endometriosis
- Pelvic floor muscle tenderness in women having investigative laparoscopy for pelvic pain
- The pelvic microbiome in endometriosis
- Improve pre-operative prediction of absence of endometriosis in people with pelvic pain
- Biomarkers of endometriosis - sEV Study
- You don’t have endometriosis – Endo Gut Study
Studies running at the centre, that do not require new participants:
- ENDometriosis and CArdioMetabolic disease risk - Epworth ENDCAM Study
- Repurposing Positron Emission Tomography (PET) Imaging for the Diagnosis and Surveillance of Endometriosis - REPETE Study
- Is Anti-Mullerian Hormone (AMH) affected by severity of endometriosis: AMH Endo Stage Study
If you have diagnosed or suspected endometriosis:
-
Anti-Mullerian hormone
Assessing change in Anti-Mullerian Hormone (ovarian reserve) associated with surgical excision vs conservative management of endometrioma: A longitudinal cohort study
This study aims to investigate how ovarian reserve changes over time in patients with endometriomas left alone compared to those who have endometriomas surgically removed.
This study will assess the ovarian reserve using a blood test to measure anti-Mullerian hormone (AMH), which is secreted by the ovary and correlates with the number of available follicles (hosting future eggs).
Who can participate?
Epworth patients aged 25-37 presenting with an ultrasound diagnosis of endometrioma (defined as the presence of one or more endometriosis ovarian cysts ≥2cm diameter) may be eligible to participate in this study.
Email [email protected] to find out more from our research team.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Dr Vanessa Ross A/Prof Martin Healey
Dr Keryn Harlow
Dr Charlotte Reddington
Dr Claudia Cheng
Dr Michal Amir
Dr Uri Dior
A/Prof Kate Stern
Dr Jacqueline Donoghue
Prof Richard Anderson
Prof Peter RogersRoyal Women’s Hospital University of Melbourne
Mercy Hospital for Women
Frances Perry House
Melbourne IVF
NewLife IVF
Holmesglen Private Hospital
Western Health (Joan Kirner)
Warringal Private Hospital
St Vincent’s Private Hospital
Monash Health
City Fertility
Northpark Private
Peninsula Private Hospital
Beleura Private
Hadassah-Hebrew University Medical Centre -
Endo Barostat Study
Understanding the causes of gastrointestinal symptoms in people with endometriosis – a pilot study
People who suffer from endometriosis often suffer from IBS and/or gastrointestinal (GI) symptoms (e.g. bloating, abdominal pain, constipation and diarrhoea). However, we still do not know what causes these GI symptoms associated with endometriosis. This study aims to identify the cause of GI symptoms in women with endometriosis. Specifically focusing on whether these symptoms are caused by chronic inflammation and/or as a result of having a highly sensitive gut wall.
Who can participate?
You may be eligible for this study if you:
- live in metro Melbourne
- are over 18 years of age
- have been diagnosed with endometriosis and IBS
- are not pregnant or breastfeeding
- are not recovering from recent abdominal surgery
- are not suffering from another gut disorder i.e. coeliac disease
- have no history of hysterectomy, oophorectomy or bowel resection.
To find out more, email [email protected] or take the study screening survey and a member of the research team will be in touch.
Epworth location Principal Investigator Other Investigator(s) Leading Collaborator Site Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
A/Prof Rebecca Burgell
A/Prof Jane Muir
Dr Jane Varney
Prof Jane FisherDr Veran PerananthanProf Mark MorrisonDr Judith MooreDr Roni RatnerMonash University EndoActive
Endometriosis Australia
-
Endometriosis Longitudinal Fertility Study (ELFS)
A prospective longitudinal cohort study of the effect of conservative and surgical management for moderate to severe endometriosis on future fertility
This study will document the monthly chances of pregnancy from trying naturally in two groups of patients: those who have had surgery and those who have not. The same comparison will also be made for patients trying for pregnancy through in vitro fertilisation (IVF). In addition, this study will assess the effect of no surgery compared to surgery on future pregnancy in patients who are not yet trying to start a family.
Who can participate?
Epworth patients may be eligible if you:
- are less than 38 years of age
- have desire for fertility (current or future)
- have evidence of untreated moderate or severe endometriosis on diagnostic laparoscopy or expert imaging.
Email [email protected] to find out more from our research team.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Dr Vanessa Ross Dr Samantha Mooney
Dr Carmel McInerney
A/Prof Martin Healey
Dr Keryn Harlow
Dr Charlotte Reddington
Dr Claudia Cheng
Dr Michal Amir
Dr Uri Dior
A/Prof Kate Stern
Prof Peter Rogers
Royal Women’s Hospital University of Melbourne
Mercy Hospital for Women
Western Health (Joan Kirner)
Frances Perry House
Melbourne IVF
NewLife IVF
Warringal Private Hospital
Hadassah-Hebrew University Medical Centre -
LongSTEPPP Study
Longitudinal Study of Teenagers with Endometriosis, Period and Pelvic Pain in Australia
The LongSTEPPP project aims to find out how we can best care for young people experiencing period pain, pelvic pain, or who may have suspected or confirmed endometriosis.
The project asks you and your parent/guardian to complete annual questionnaires (about periods, pain, quality of life and mental health) which take about an hour per year, done online at your own pace. Young people don’t see how their parent answers and vice versa.
Who can participate?
You may be eligible for this study if:
- you are between the ages of 10 and 18 years
- you ave been referred to a gynaecologist for dysmenorrhoea, pelvic pain, and suspected or diagnosed endometriosis
- both you and your parent/guardian are willing to take part.
To find out more from our research team, email [email protected]
Epworth location Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Epworth Geelong
Professor Sonia Grover Prof Harriet Hiscock
Prof Catherine Bennett
Dr Courtney Munro
Prof Andrew Chanen
Dr Rebecca Deans
Dr Julie Abimanyi-OchomMurdoch Children’s Research Institute The Canberra Hospital
Royal Hospital for Women
John Hunter Hospital
Sydney Children’s Hospital
The Children’s Hospital at Westmead
Royal Darwin Hospital
Mater Hospital
Women’s and Children’s Hospital
Family Planning Tasmania
Royal Hobart Hospital
Monash Children’s Hospital
Royal Children’s Hospital
Deakin University -
MISs-ENDO: Miscarriage and Endometriosis, A prospective longitudinal cohort study
This study aims to investigate the potential association between endometriosis and miscarriage. Pregnancy outcomes of a large group of women who have evidence of moderate to severe endometriosis (EMSE) will be observed and compared to patients who have never been diagnosed with endometriosis. The outcomes of this study may help researchers and clinicians understand the link between endometriosis and miscarriage, potentially guiding future research for healthier pregnancies.
Who can participate?
You may be eligible for this study if you:
- <38 years of age
- Have a desire for fertility (current or future), including those with infertility
- Previous gynaecological laparoscopic surgery indicating NO endometriosis (any indication) within 24 months of enrolment, OR no prior diagnosis of endometriosis AND no history of significant period pain (dysmenorrhea) necessitating specialist input AND an expert tertiary level ultrasound demonstrating absence of findings consistent with endometriosis.
To find out more from our research team, email [email protected]
Epworth location Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Epworth Freemasons
Epworth Richmond
Dr Samantha Mooney Dr Vanessa Ross
A/Prof Martin Healey
A/Prof Sarah Holdsworth-Carson
Dr Kate Tyson
A/Prof Kate Stern
Prof Peter RogersUniversity of Melbourne -
NECST Registry
National Endometriosis Clinical and Scientific Trials (NECST) Registry
This project aims to establish a National Endometriosis Clinical Registry to facilitate high-quality research that will help and improve the understanding, diagnosis, treatment and prognosis for people diagnosed with endometriosis and adenomyosis.
The NECST Registry also aims to assess the long-term impact and life courses of endometriosis symptoms and diagnosis, consistent with the research objectives in the National Action Plan for Endometriosis and RANZCOG Clinical Practice Guidelines for the Diagnosis and Management of Endometriosis.
Who can participate?
You may be eligible for this study if you are over 18 years of age, and:
- are being investigated due to symptoms possibly relating to endometriosis or adenomyosis (e.g. persistent pelvic pains, problems with fertility, abnormal uterine bleeding, etc), or
- you been diagnosed with endometriosis and/or adenomyosis, or
- are being managed with symptoms relating to endometriosis and/or adenomyosis.
To find out more from our research team, email [email protected].
Epworth location Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Epworth Geelong
Professor Jason Abbott A/Prof Jim Tsaltas
Prof Luk Rombauts
Dr Sarah Holdsworth-Carson
Dr Kate Tyson
Prof Grant Montgomery
Prof Gita Mishra
A/Prof Anusch Yazdani
Dr Cecilia Ng
Dr Danny Chou
Dr Supuni Kapurubandara
Prof Peter Rogers
Dr Matin Ritossa
Prof Louise Hull
A/Prof Krish Karthigasu
University of New South Wales
Royal Hospital for Women
St George Hospital
Westmead Hospital
Monash Health
Royal Women’s Hospital
Lyell McEwin Hospital
Modbury Hospital
Women’s and Children’s Hospital
Mater Misericordiae (pending)
King Edward Memorial Hospital (pending) -
Non-invasive endometriosis diagnosis using machine learning – the “Imagendo” Study
Currently, the only reliable way of diagnosing endometriosis is through keyhole surgery, which can be risky and expensive. This research project aims to improve the ability to diagnose endometriosis without surgery, by combining the digital information from endometriosis-specific ultrasound scans and MRI (magnetic resonance imaging) tests, using computer algorithms (machine learning).
Who can participate?
You may be eligible for this study if you:
- Are aged 18 to 45 years
- Have symptoms of endometriosis
- Have recently had an endometriosis specific ultrasound or MRI
To find out more from our research team, email [email protected]
Epworth location Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Dr Samantha Mooney Prof Louise Hull
Dr Jodie Avery
A/Prof Natalie Yang
A/Prof Sarah Holdsworth-Carson
A/Prof Eddie Lau
A/Prof Emma Readman
A/Prof George Condous
Prof Gustavo Carneiro
Dr Jane WoolcockThe University of Adelaide
Nepean Hospital
Austin Health
Monash University
Robinson Research Institute
If you are planned/scheduled for surgery:
-
Aetiology of Endometriosis
This study aims to better understand the aetiology or cause of endometriosis and find ways to diagnose the condition using menstrual fluid. Biospecimens will be collected during hysterectomy/laparoscopy to evaluate genetic risk in patients with endometriosis.
Menstrual fluid can also be collected on day 2 while the person is waiting for their surgery. A kit with a menstrual cup (for use and keeping) will be delivered to the home or workplace of the participant and picked up 4 to 6 hours later (on day 2) in a contactless, COVID-safe manner.
Who can participate?
Epworth patients scheduled for laparoscopic (or hysterectomy) procedure for diagnosis and/or excision of endometriosis or other benign gynaecological disorder and aged 18-50 years may be eligible to participate in this study. Email [email protected] to find out more from our research team.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
A/Prof Jim Tsaltas Prof Caroline Gargett
Dr Harriet Fitzgerald
Dr Kate Tyson
Dr Roni Ratner
Christina Halstead
Madison Bates
Maria PetrakiHudson Institute of Medical Research Monash Health
University of Queensland
-
Developing and evaluating a screening tool to improve pre-operative prediction of absence of endometriosis in people with pelvic pain
Persistent Pelvic Pain (PPP) is very commonly associated with endometriosis. However, when laparoscopies are undertaken to look for endometriosis associated with PPP, approximately one third of patients will not have endometriosis if their ultrasound beforehand was “normal”. Therefore, up to one third of patients undergo surgery for conditions that could be treated non-surgically.
This study will be asking patients who are already planning to have a laparoscopy for investigation of their PPP to fill out a questionnaire about their symptoms and medical history before their operation. We will also measure their anogenital distance (distance between from the vagina to the anus, which is associated with chance of endometriosis) while they are asleep under the anaesthetic for their surgery. We will then check if endometriosis was diagnosed and use this all of this information to develop an “endometriosis calculator” that can predict if endometriosis is likely to be diagnosed in a person with PPP.Who can participate?
You may be eligible for this study if you:
- are between the age of 18 and 45
- are experiencing persistent pelvic pain
- are scheduled for a laparoscopy for possible endometriosis
- have had an ultrasound within the last 24 months that shows no evidence of endometriosis.
Email [email protected] to find out more from our research team.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Dr Charlotte Reddington Dr Samantha Mooney
Dr Lenore Ellett
Dr Uri Dior
Dr Keryn Harlow
Dr Lauren Hicks
Dr Claudia Cheng
Dr Emma Readman
Dr Michal Amir
A/Prof Jim Tsaltas
Ms Melissa Parker
Dr Jane Girling
A/Prof Sarah Holdsworth-Carson
Prof Peter Rogers
A/Prof Martin HealeyRoyal Women's Hospital Mercy Hospital for Women, VIC
Frances Perry House, VIC
Warringal Private Hospital, VIC
Hadassah-Hebrew University
Medical Centre, Jerusalem, Israel -
EnD-IT: Better diagnosis of initial and recurrent endometriosis
This study is divided into two projects. Both aim to improve the quality of life for those living with endometriosis through improved diagnosis of initial and recurrent disease.
Project 1: Aims to establish a clinical prediction tool or questionnaire to help estimate the likelihood of recurrent endometriosis.
Project 2: Aims to identify new non-invasive endometriosis biomarkers.
Who can participate?
Patients scheduled for laparoscopic procedure for diagnosis and/or management of pelvic and/or endometriosis at Epworth HealthCare, and aged 18-45 years may be eligible for this study.
Email [email protected] to find out more from our research team.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Dr Sarah Holdsworth-Carson Dr Meaghan Griffiths
Dr Charlotte Reddington
Dr Jacqueline Donoghue
Dr Michal Amir
Dr Vanessa Ross
Dr Kate Tyson
A/Prof Berin Boughton
A/Prof Jane Girling
A/Prof Kate Stern
Dr Claudia Cheng
Dr Samantha Mooney
Dr Lenore Ellett
A/Prof Emma Readman
A/Prof Martin Healey
Prof Peter RodgersRoyal Women’s Hospital University of Melbourne
Mercy Hospital for Women
Frances Perry House
Warringal Hospital -
Endo Gut Study
Exploring the prevalence, type and frequency of bowel symptoms in people with, and without endometriosis and the role of psychological distress and endometriosis phenotype on symptom generation
People with endometriosis often experience chronic abdominal pain and bowel symptoms such as bloating, constipation and diarrhoea. These gut symptoms are also characteristics of irritable bowel syndrome (IBS). This study aims to explore the differences between IBS and endometriosis by distinguishing the types of symptoms experienced, how these symptoms affect day to day living and to identify differences in the types of bacteria that inhabit the gut and vagina of people with and without endometriosis.
Who can participate?
You may be eligible for this study if you:
- are over 18 years of age
- have been told you do not have endometriosis following a laparoscopy, and
- experience gut symptoms such as bloating, diarrhoea and/or constipation.
You can also participate in the study if you are a healthy individual who does not have endometriosis or experience gut symptoms.
To find out more, email [email protected]
Epworth location Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Epworth Geelong
A/Prof Rebecca Burgell
A/Prof Professor Jane Muir
Dr Jane Varney
Prof Jane Fisher
Prof Mark Morrison
Dr Roni RatnerMonash University University of Queensland
-
JAECE Biobank
Julia Argyrou Endometriosis Centre at Epworth
The JAECE Biobank is a prospective study which aims to collect biospecimens and clinical data from patients with both endometriosis and benign gynaecological conditions for future ethics-approved research. Building a research biobank is key to delivering evidence-based improved healthcare services and outcomes for endometriosis. Specimens collected for the biobank include blood, peritoneal fluid, endometriotic lesions, endometrioma, endometrium and hysterectomy specimens.
Who can participate?
You may be eligible for this study if you are:
- 18 years or older
- pre-menopausal
- planned for surgery (laparoscopy or laparotomy) and/or gynaecological procedure (hysteroscopy with dilation and curettage [D&C]) for investigation and/or management of endometriosis OR a benign gynaecological condition at Epworth HealthCare.
To find out more from our research team, email [email protected]
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Epworth Freemasons
Epworth Richmond
Dr Sarah Holdsworth-Carson Dr Kate Tyson Epworth Healthcare -
MRI-ENDO
Assessing the role of Magnetic Resonance Imaging (MRI) as a non-invasive, early diagnostic method for endometriosis in adolescents and young adults: MRI-ENDO Study
This study aims to determine the sensitivity and specificity for MRI in endometriosis in young patients.
Who can participate?
Epworth patients aged 16-25 years of age, who are clinically suspected of having endometriosis and are planned for a laparoscopy at Epworth HealthCare may be eligible for this study. Email [email protected] to find out more from our research team.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Epworth Eastern
Epworth Geelong
Dr Kate Tyson Dr Sarah Holdsworth-Carson
Dr Natalie Yang
Dr Karyn ChanEpworth Healthcare Austin Health
-
Palmitoylethanolamide and polydatin
Palmitoylethanolamide and polydatin effect on pain and dysmenorrhea in women scheduled for laparoscopic treatment of possible endometriosis: a double blind randomised controlled trial
A double blinded randomised controlled trial where participants will be either allocated to the treatment cohort (palmitoylethanolamide/polydatin) or the placebo cohort. This trial aims to compare the pain scores and quality of life between the two groups to see if PEA/PLD improves endometriosis-related pain.
Who can participate?
Epworth patients who are 18 to 45 years of age with pelvic pain, and scheduled for laparoscopic treatment of known endometriosis based on previous laparoscopy or ultrasound may be eligible for this trial. Email [email protected] to find out more from our research team.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
A/Prof Martin Healey Dr Michal Amir
Dr Charlotte Reddington
Dr Claudia Cheng
Dr Keryn Harlow
A/Prof Emma Readman
Dr Lenore Ellett
Dr Samantha Mooney
Dr Vanessa Ross
Dr Lauren Hicks
Dr Stephanie Teague
Dr Sarah Holdsworth-Carson
Dr Jacqueline Donoghue
Prof Peter RogersRoyal Women's Hospital Mercy Hospital for Women
Frances Perry House
Cabrini Private Hospital – Malvern
Holmesglen Private Hospital
Sunshine Hospital
Warringal Hospital
Sandringham Hospital
-
Pelvic floor muscle tenderness
Pelvic floor muscle tenderness in women having investigative laparoscopy for pelvic pain: a prospective cohort study
Prior to a participant’s first laparoscopy for the investigation of persistent pelvic pain, this study will investigate if they experience tenderness and tension in their pelvic floor muscles, and whether this is associated with their pelvic pain.
This study will also investigate whether the pelvic floor muscle tenderness and tension, and pelvic pain, change following the laparoscopy. It will investigate this in the short term (3 months) and the medium term (1 year).
Who can participate?
Epworth patients aged 18-50 years with pelvic pain for 6 months or longer may be eligible for this study. You must also:
- be scheduled for a laparoscopy for investigation of pelvic pain
- have no prior history of surgically treated endometriosis.
Email [email protected] to find out more from our research team.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Dr Claudia Cheng A/Prof Helena Frawley
Dr Keryn Harlow
Dr Samantha Mooney
Dr Lenore Ellett
Dr Lauren Hicks
Dr Charlotte Reddington
A/Prof Emma Readman
Dr Michal Amir
A/Prof Martin Healey
Prof Peter RogersRoyal Women’s Hospital University of Melbourne
Mercy Hospital for Women
Frances Perry House
Cabrini Health
Holmesglen Private Hospital
Western Health (Joan Kirner)
Warringal Private Hospital
St Vincent’s Private Hospital -
Pelvic microbiome
The pelvic microbiome in endometriosis: A prospective case-control study (PELME)
This study aims to investigate the pelvic microbiome of patients with endometriosis compared to those without. Biospecimens will be collected during laparoscopy and analysed to identify organisms.
Who can participate?
Epworth patients scheduled for laparoscopy for treatment of previously confirmed or clinically suspected endometriosis, or other benign gynaecological conditions, and are 18 years or older may be eligible to participate in this study.
Email [email protected] to find out more from our research team.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Dr Lior Levy A/Prof Jim Tsaltas
Dr Kate Tyson
Dr Lima Wetherell
Dr Phil Thomas
Dr Roni Rattner
Epworth HealthCare Monash Health
-
sEV Study
Exosomes as Peripheral Biomarkers of Endometriosis
This study aims to isolate endometriosis-specific extracellular vesicles from peritoneal fluid of endometriosis patients and then compare these to vesicles from peripheral blood of the same patients to see if these vesicles may serve as biomarkers of endometriosis. If blood-borne biomarkers specific to endometriosis are found as a result of this research, future patients could be diagnosed with a simple blood test.
Who can participate?
You may be eligible for this study if you:
- are aged between 18 and 49 years
- are pre-menopausal
- are scheduled to undergo elective gynaecological laparoscopy or hysterectomy, for various benign gynaecological conditions (e.g. diagnostic laparoscopy for chronic pelvic pain, treatment of previously confirmed or clinically suspected endometriosis, treatment of ovarian cysts, tubal ligation, treatment of fibroids, etc.)
- are not currently pregnant
- do not have any malignancies confirmed on recent histopathological reports
To find out more, email [email protected] and a member of the research team will be in touch.
Epworth location Epworth Principal Investigator Other Investigator(s) Leading Collaborator Site(s) Other Collaborating Site(s) Epworth Freemasons
Epworth Richmond
Dr Kate Tyson Dr Thomas Tapmeier
Prof Beverley Vollenhoven
Prof Caroline GargettMonash University
Hudson Institute for Medical Research
Monash HealthJessie MacPherson Private Hospital
Waverley Private Hospital
Cabrini Hospital
Monash Surgical Private Hospital
Mount Waverley Private Hospital
Sandringham & District Memorial Hospital
Sunshine Hospital
Studies running at the centre, that do not require new participants:
-
ENDometriosis and CArdioMetabolic disease risk - Epworth ENDCAM Study
This study will employ hospital admission data between 2006 to 2022 from Epworth HealthCare to determine if there are differences in the number and type of cardiometabolic conditions diagnosed in patients with endometriosis compared to those without endometriosis. This project has received human research ethics committee approval for waiving consent. The outcome of this project will help to provide clinicians with the evidence to implement early monitoring of endometriosis patients, controlling for future cardiometabolic risk.
Epworth location Principal Investigator Other investigator(s) Leading collaborator site(s) Epworth, VIC A/Prof Sarah Holdsworth-Carson Dr Kate Tyson
Dr Samantha Mooney
Dr Tarana Lucky
A/Prof Monique Watts
Mr Kai Hamilton
A/Prof Dean McKenzieEpworth HealthCare -
Is Anti-Mullerian Hormone (AMH) affected by severity of endometriosis: AMH Endo Stage Study
Anti-Mullerian Hormone (AMH) is a marker used to measure ovarian reserve. Previous studies have shown a decline in AMH with ovarian endometriosis. The study will access human tissue bank specimens. This study will assess if there is a difference in AMH with minimal/mild endometriosis compared to moderate/severe endometriosis. The study will increase our understanding of endometriosis- related infertility, allowing clinicians to better counsel patients regarding their long-term reproduction outcomes and fertility preservation needs.
Epworth location Principal Investigator Other investigator(s) Leading collaborator site(s) Other collaborating site(s) Epworth, VIC Dr Lenore Ellett Dr Keryn Harlow
Dr Rebecca Mann
A/Prof Martin Healey
Dr Jacqueline Donoghue
A/Prof Sarah Holdsworth-Carson
Prof Peter RogersThe Royal Women’s Hospital University of Melbourne -
Repurposing Positron Emission Tomography (PET) Imaging for the Diagnosis and Surveillance of Endometriosis – REPETE Study
The REPETE Study is aiming to establish if positron emission tomography (PET) imaging could be repurposed for investigation, diagnosis and surveillance of endometriosis. The study will access human tissue bank specimens of uterine and endometriosis tissues to undertake immunohistochemistry (IHC) experiments. The study will target antigens and receptors of existing PET tracers, that demonstrate biological plausibility in the setting of endometriosis (for example, but not limited to, estrogen receptors and fibrosis).
Epworth location Principal Investigator Other investigator(s) Leading collaborator site(s) Epworth, VIC A/Prof Sarah Holdsworth-Carson Dr Kate Tyson
Dr Samantha Mooney
Dr Lauren Hicks
Dr Rachael Fox
Prof Peter Rogers
Prof Paul Donnelly
Prof Rodney HicksThe Royal Women’s Hospital -
OBS-ENDO at Epworth: Obstetric Outcomes in Patients with Pre-pregnancy Endometriosis
This study will use Epworth pregnancy outcome data and data from Epworth inpatient hospital admissions for surgical procedures, to retrospectively assess whether any association exists between a history of surgical treatment of (any) endometriosis and poor pregnancy outcomes for mothers or their babies. This study will also assess whether the type of endometriosis (e.g. the severity and the pelvic tissues involved) has any relationship to the subsequent obstetric and neonatal outcomes.
Epworth location Principal Investigator Other investigator(s) Leading collaborator site(s) Other collaborating site(s) Epworth Freemasons, VIC
Epworth Richmond, VICDr Samantha Mooney A/Prof Martin Healey
A/Prof Sarah Holdsworth-Carson
Dr Vanessa Ross
Mr Kai Hamilton
A/Prof Dean McKenzie
Dr Kate Tyson
Prof Kate Stern
Prof Jason Abbott
Prof Georgina Chambers
Prof Peter Rogers
Epworth HealthCare
If you have any questions about the current research studies or clinical trials or to make a referral, please contact us on:
Phone: 03 9516 2434
Email: [email protected]
Updates: Sign up for our newsletter
About endometriosis
- What is endometriosis
- What causes endometriosis
- What are the symptoms
- What are the risk factors
- Myths surrounding endometriosis
